Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV801
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,230
Award facts
- Contract value 100% obligated
- $18,229.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,229.57 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania and completion expected by January 26, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement and supplies products across multiple therapeutic domains to military and veteran healthcare systems.
This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Ondansetron, an anti-nausea medication commonly used in military medical settings, represents one of many pharmaceutical products delivered under this strategic contract vehicle.
Quick answers
Who was awarded contract SPE2DR26FV801?
SPE2DR26FV801 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FV801 worth?
The government has obligated $18,230 on SPE2DR26FV801.
Is contract SPE2DR26FV801 an order under another contract?
Yes. SPE2DR26FV801 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV801 competed?
The extent of competition for SPE2DR26FV801 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award